Market Cap 17.75M
Revenue (ttm) 2.69M
Net Income (ttm) -8.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -306.32%
Debt to Equity Ratio 0.00
Volume 207,445
Avg Vol 2,030,790
Day's Range N/A - N/A
Shares Out 7.22M
Stochastic %K 27%
Beta 3.09
Analysts Strong Sell
Price Target $7.00

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly kno...

Industry: Biotechnology
Sector: Healthcare
Phone: 812 689 0791
Address:
11611 North Meridian St, Suite 330, Carmel, United States
woolpourpis69
woolpourpis69 Jul. 17 at 6:15 PM
0 · Reply
Slab6
Slab6 Jul. 14 at 10:59 PM
$NRXS slowly adding here
0 · Reply
Gurss
Gurss Jul. 14 at 5:23 PM
0 · Reply
Eqdis999
Eqdis999 Jul. 10 at 2:29 PM
$NRXS LONG! great multi year hold seems
0 · Reply
BrielleX_619
BrielleX_619 Jul. 9 at 1:35 PM
$NRXS ⁨WKSP: U.S. factory ✅ 50%+ prod growth ✅ Doubling margins ✅ Nano-grid + solar Q3 rollout ✅ 1K-truck federal pilot ✅ No China exposure 🔥EYES ON $7+⁩
0 · Reply
Gurss
Gurss Jul. 8 at 6:42 PM
$BMEA , $NRXS buy
0 · Reply
warayu
warayu Jul. 8 at 7:48 AM
$NRXS go go go NRXS
0 · Reply
KCclean
KCclean Jul. 8 at 2:51 AM
$NRXS long against this cluster of moving averages
0 · Reply
Slab6
Slab6 Jul. 7 at 5:44 PM
0 · Reply
woolpourpis69
woolpourpis69 Jul. 7 at 4:18 PM
0 · Reply
Latest News on NRXS
NeurAxis Announces $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 2 months ago

NeurAxis Announces $5.0 Million Registered Direct Offering


NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 1:58 PM EDT - 2 months ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript


NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 4:18 PM EDT - 4 months ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript


NeurAxis Inc. Issues Letter to Shareholders

Jan 13, 2025, 9:00 AM EST - 6 months ago

NeurAxis Inc. Issues Letter to Shareholders


NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 2:04 PM EST - 8 months ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript


NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 5:44 AM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript


NeurAxis Reports Second Quarter 2024 Financial Results

Aug 9, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2024 Financial Results


NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 1:34 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript


NeurAxis Reports First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports First Quarter 2024 Financial Results


NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 6:45 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript


NeurAxis Announces Highmark BCBS Policy Coverage

Mar 11, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Highmark BCBS Policy Coverage


NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Jan 31, 2024, 9:00 AM EST - 1 year ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer


NeurAxis Reports Third Quarter 2023 Financial Results

Nov 20, 2023, 5:30 PM EST - 1 year ago

NeurAxis Reports Third Quarter 2023 Financial Results


NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 15, 2023, 9:00 AM EST - 1 year ago

NeurAxis Announces CareFirst BCBS Policy Coverage


NeurAxis Secures $3 Million Financing

Nov 14, 2023, 9:00 AM EST - 1 year ago

NeurAxis Secures $3 Million Financing


NeurAxis Reports Second Quarter 2023 Financial Results

Sep 21, 2023, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2023 Financial Results


NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 29, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study


NeurAxis Highlights Strength of its Board of Directors

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors


NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Aug 17, 2023, 9:02 AM EDT - 2 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue


woolpourpis69
woolpourpis69 Jul. 17 at 6:15 PM
0 · Reply
Slab6
Slab6 Jul. 14 at 10:59 PM
$NRXS slowly adding here
0 · Reply
Gurss
Gurss Jul. 14 at 5:23 PM
0 · Reply
Eqdis999
Eqdis999 Jul. 10 at 2:29 PM
$NRXS LONG! great multi year hold seems
0 · Reply
BrielleX_619
BrielleX_619 Jul. 9 at 1:35 PM
$NRXS ⁨WKSP: U.S. factory ✅ 50%+ prod growth ✅ Doubling margins ✅ Nano-grid + solar Q3 rollout ✅ 1K-truck federal pilot ✅ No China exposure 🔥EYES ON $7+⁩
0 · Reply
Gurss
Gurss Jul. 8 at 6:42 PM
$BMEA , $NRXS buy
0 · Reply
warayu
warayu Jul. 8 at 7:48 AM
$NRXS go go go NRXS
0 · Reply
KCclean
KCclean Jul. 8 at 2:51 AM
$NRXS long against this cluster of moving averages
0 · Reply
Slab6
Slab6 Jul. 7 at 5:44 PM
0 · Reply
woolpourpis69
woolpourpis69 Jul. 7 at 4:18 PM
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 3 at 5:23 PM
$NRXS terminates Masimo licensing deal, losing 7% of 2024 revenue stream. Now owes $200K in payments through 2026. New employee stock plan offers 15% discount - curious timing given cash burn of $1.6M/quarter. High-risk profile intensifies with this revenue hit. https://www.sec.gov/Archives/edgar/data/1933567/000164117225017723/form8-k.htm
0 · Reply
Carrotcake
Carrotcake Jul. 3 at 12:28 PM
$NRXS starter.
0 · Reply
biggercapital
biggercapital Jul. 2 at 1:39 PM
Long size $NRXS
1 · Reply
Gurss
Gurss Jul. 2 at 12:06 PM
0 · Reply
Gurss
Gurss Jun. 26 at 10:37 PM
0 · Reply
Gurss
Gurss Jun. 26 at 4:49 PM
$NRXS buy
0 · Reply
UpsideRide
UpsideRide Jun. 26 at 2:02 PM
Bought $ENVX $NRXS this morning, lets GO!
0 · Reply
cleverrox
cleverrox Jun. 23 at 6:10 PM
New full depth article on Neuraxis $NRXS https://microcapopportunities.substack.com/p/neuraxis-nrxs-a-steal-at-current
0 · Reply
wallstpirate
wallstpirate Jun. 19 at 11:35 AM
$NRXS RE: Adult ib stim: Sergio an SA and Substack analyst asked them about adult ib stim on the Q3 /24 cc which is on this printed transcript link on bottom. And then another question I get to ask is, why isn't it available for adults? And will you be shooting in that direction? Brian Carrico Yes, that's another great question, Sergio. We're going to release a new deck today that will be in our IR firm. And we just haven't gotten to talk about that in our earnings calls yet, but we are well on our way to approaching the FDA for an adult indication expansion that would range from 21 through all adult ages. And I believe that we're aiming for late 2025 to earn that FDA indication. They also say it is a much larger market > 2B etc. Worth the read. https://seekingalpha.com/article/4737932-neuraxis-inc-nrxs-q3-2024-earnings-call-transcript
0 · Reply
wallstpirate
wallstpirate Jun. 19 at 11:33 AM
$NRXS From cc: Regarding children's hospitals, many have been ordering for years, but for a variety of reasons, we have not received early insurance policy coverage in those geographic regions. Once insurance policy coverage is written in these areas, the children's hospitals are expected to increase revenue very quickly because the product is already in their system, therefore, not needing the 120 days to get set up. The second part of the seamless treatment for patients, along with policy coverage is the Category I CPT code.
0 · Reply
JcCapital
JcCapital Jun. 18 at 4:20 PM
$NRXS will pop soon..be patient
0 · Reply
wallstpirate
wallstpirate Jun. 18 at 12:22 PM
$NRXS Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal Pain https://www.nasdaq.com/articles/neuraxis-inc-expands-insurance-coverage-ib-stim-therapy-enhancing-access-patients
0 · Reply